Omeprazole enteric-coated capsules
Function and Efficacy
Proton pump inhibitor. This product is a fat-soluble weakly alkaline drug that is easily concentrated in an acidic environment. Therefore, after oral administration, it can be specifically distributed in the secretory tubules of the gastric mucosal parietal cells and converted into the active form of sulfenamide in this high-acid environment. Then, it irreversibly combines with the sulfhydryl group of the H,K-ATPase (also known as the proton pump) in the secretory membrane of the parietal cells through a disulfide bond to form a complex of sulfenamide and the proton pump, thereby inhibiting the activity of the enzyme and blocking the final step of gastric acid secretion. Therefore, this product has a strong and lasting inhibitory effect on gastric acid secretion caused by various reasons.
Ingredients
The main ingredient of this product is omeprazole.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| OmeprazoleIngredients |
Proton pump inhibitor. This product is a fat-soluble weak alkaline drug that is easily concentrated in an acidic environment. Therefore, after oral administration, it can be specifically distributed in the secretory tubules of the gastric mucosal parietal cells and converted into the active form of sulfenamide in this high-acid environment. Then, it irreversibly combines with the sulfhydryl group of the H,K-ATPase (also known as the proton pump) in the secretory membrane of the parietal cells through a disulfide bond to form a complex of sulfenamide and the proton pump, thereby inhibiting the activity of the enzyme and blocking the final step of gastric acid secretion. Therefore, this product has a strong and lasting inhibitory effect on gastric acid secretion caused by various reasons. More |
73590-58-6 | 83 |
Appearance
This product is a capsule, and the contents are white or off-white enteric-coated pills or granules.
Indication
Indicated for gastric ulcer, duodenal ulcer, stress ulcer, reflux esophagitis and Zollinger-Ellison syndrome (gastrinoma)
Usage and Dosage
Oral administration, do not chew. 1. Peptic ulcer: 1 tablet (20 mg) at a time, 1 to 2 times a day. Swallow in the morning or once in the morning and evening. The treatment course for gastric ulcer is usually 4 to 8 weeks, and the treatment course for duodenal ulcer is usually 2 to 4 weeks. 2. Reflux esophagitis: 1 to 3 tablets (20 to 60 mg) at a time, 1 to 2 times a day. Swallow in the morning or once in the morning and evening. The treatment course is usually 4 to 8 weeks. 3. Zollinger-Ellison syndrome: 3 tablets (60 mg) at a time, once a day. The total daily dose can be adjusted to 1 to 6 tablets (20 to 120 mg) according to the condition. If the total daily dose needs to exceed 4 tablets (80 mg), it should be taken in 2 doses.
Adverse Reactions
This product is well tolerated. Common adverse reactions include diarrhea, headache, nausea, abdominal pain, flatulence and constipation. Occasionally, serum aminotransferase (ALT, AST) increases, rash, dizziness, drowsiness, insomnia, etc. These adverse reactions are usually mild, disappear automatically, and are not related to the dose. No serious adverse reactions have been observed in long-term treatment, but gastric mucosal cell hyperplasia and atrophic gastritis may occur in some cases.
Precautions
It is contraindicated for patients who are allergic to this product, those with severe renal insufficiency and infants.
Special Population Medication
Precautions for children: There is no experience of using the drug for children, and it is forbidden to use it for infants and young children. Precautions for pregnancy and lactation: Although this product has no teratogenic effect in animal experiments, it should generally not be used by pregnant women, and should also be used with caution by lactating women. Precautions for the elderly: It is not yet clear.
Drug Interactions
This product can delay the elimination of drugs metabolized by the liver, such as diazepam, phenytoin sodium, warfarin, nifedipine, etc. When this product is used together with the above drugs, the dosage of the latter should be reduced.
Storage
Keep away from light, seal tightly, and store in a dry place (10~30 degrees).
Packaging Specification
20 mg
Validity Period
24 months.
Manufacturer
Zhuhai Rundu Pharmaceutical Co., Ltd.
-
Founded in:
1999-12-30 -
Address:
No. 6, Airport North Road, Sanzao Town, Jinwan District, Zhuhai City -
Tax NO.:
91440400192520640G -
Registered Funds:
334.893286 million yuan -
Website:
-
Email: